how many americans are on glp 1 drugs People Take GLP-1 Medications in the US About 1 in 8 adult
Description
Highights of Prescribing Information
Among those initiating GLP1 receptor agonists, 57.5% started with liraglutide, 42.0% with semaglutide, and 0.5% with dulaglutide
The most common adverse effects of tirzepatide are gastrointestinal, including nausea (occurring in 15-30% of patients), diarrhea, vomiting, constipation, and abdominal discomfort
d , e , f
[cited 2025 Apr 7]
